The Goldman Sachs Group Raises Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $33.00
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its target price hoisted by The Goldman Sachs Group from $30.00 to $33.00 in a report released on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities research analysts have also recently weighed in on SNDX. Citigroup lifted their price […]
More Stories
Coca-Cola FEMSA (KOF) – Investment Analysts’ Weekly Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Coca-Cola FEMSA (NYSE: KOF) in the last few...
Trump Picks Tulsi Gabbard as Director of National Intelligence
By Ryan Morgan President-elect Donald Trump has named former congresswoman Tulsi Gabbard as his pick for the director of national...
Short Interest in Engie SA (OTCMKTS:ENGIY) Rises By 440.7%
Engie SA (OTCMKTS:ENGIY – Get Free Report) was the target of a large increase in short interest in the month...
Global Mofy Metaverse Limited (NASDAQ:GMM) Short Interest Update
Global Mofy Metaverse Limited (NASDAQ:GMM – Get Free Report) was the recipient of a significant increase in short interest in...
Short Interest in MFS High Yield Municipal Trust (NYSE:CMU) Increases By 347.6%
MFS High Yield Municipal Trust (NYSE:CMU – Get Free Report) saw a large growth in short interest during the month...
iShares North American Natural Resources ETF (BATS:IGE) Reaches New 12-Month High – Here’s What Happened
iShares North American Natural Resources ETF (BATS:IGE – Get Free Report) reached a new 52-week high during mid-day trading on...